Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Target mutations in lung cancer

Dr Romain Corre - Rennes University Hospital, Rennes, France
Target mutations in lung cancer ( Dr Romain Corre - Rennes University Hospital, Rennes, France )
22 Nov 2016

Inclusion of elderly patients in clinical trials

Olivia Le Saux - Hospices Civils de Lyon, Lyon, France
Inclusion of elderly patients in clinical trials ( Olivia Le Saux - Hospices Civils de Lyon, Lyon, France )
22 Nov 2016

The impact of radiation toxicity on quality of life

Prof Anita O’Donovan - Trinity College Dublin, Dublin, Ireland
The impact of radiation toxicity on quality of life ( Prof Anita O’Donovan - Trinity College Dublin, Dublin, Ireland )
22 Nov 2016

Telehealth in geriatric support

Prof Annie Young - University of Warwick, Coventry, UK
Telehealth in geriatric support ( Prof Annie Young - University of Warwick, Coventry, UK )
22 Nov 2016

Utilisation of older and newer agents in treating mantle cell lymphoma

Prof Pierre Soubeyran - University of Bordeaux, Bordeaux, France
Utilisation of older and newer agents in treating mantle cell lymphoma ( Prof Pierre Soubeyran - University of Bordeaux, Bordeaux, France )
22 Nov 2016

Immunotherapy for the elderly

Prof Tamas Fulop - Université de Sherbrooke, Quebec, Canada
Immunotherapy for the elderly ( Prof Tamas Fulop - Université de Sherbrooke, Quebec, Canada )
22 Nov 2016

Elderly patients should be treated based on biological age, not chronological

Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria
Elderly patients should be treated based on biological age, not chronological ( Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria )
2 Nov 2016

miRNA screening through nipple aspiration sampling

Dr Cathy Moelans - University Medical Center Utrecht, Utrecht, Netherlands
miRNA screening through nipple aspiration sampling ( Dr Cathy Moelans - University Medical Center Utrecht, Utrecht, Netherlands )
26 Jul 2016

Editor's Choice for June 2016

Prof Gordon McVie - ecancer Editor in Chief
Editor's Choice for June 2016 ( Prof Gordon McVie - ecancer Editor in Chief )
29 Jun 2016

Older patients with AML benefit greatly from SGN-CD33 and HMA therapy combo

Dr Amir Fathi, Massachusetts General Hospital, Boston, USA
Older patients with AML benefit greatly from SGN-CD33 and HMA therapy combo ( Dr Amir Fathi, Massachusetts General Hospital, Boston, USA )
11 Jun 2016

SGN-CD33A combined with HMA therapy produces high remission rates among older patients with AML

Dr Amir Fathi - Massachusetts General Hospital, Boston, USA
SGN-CD33A combined with HMA therapy produces high remission rates among older patients with AML ( Dr Amir Fathi - Massachusetts General Hospital, Boston, USA )
11 Jun 2016

CPX-351 improves outcomes for refractory AML

Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center, Tampa, USA
CPX-351 improves outcomes for refractory AML ( Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center, Tampa, USA )
6 Jun 2016